Jennifer Walker-Journey February 25, 2013. Four drug companies have signed on to fund Protola Pharmaceuticalsâ€™ experimental antidote for reversing the effect of Factor Xa inhibitor drugs, blood thinners that block the activity of clotting Factor Xa and prevent blood clots from developing or getting worse.